BioSpecifics Technologies Corp. announced the appointment of Max Link, Ph.D. to its Board of Directors, effective August 4, 2014, with a term of office expiring and to be renewed at the 2016 Annual Meeting of Stockholders. BioSpecifics also announced that as of August 15, 2014, Henry G. Morgan will retire from the Board of Directors after 24 years of service but will continue to act in a consulting capacity.

Effective upon Mr. Morgan's retirement and in addition to serving as a Class II director, Dr. Link will be appointed as Chair of the Compensation Committee and as the Audit Committee Financial Expert.